Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma

This report demonstrates that not only heparin‐induced thrombocytopenia, but also hemodialysis conditions (platelet activation due to hemodiafiltration and heparin underdosing) may markedly reduce the platelet count and cause clotting in the hemodialysis circuit in patients in a hypercoagulable stat...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Makiko, Nakanishi, Kayoko, Masuda, Kenta, Yoshida, Kazuhiro, Shimomura, Daiki, Ishida, Atsumi, Shiga, Shuichi, Ichiyama, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452500/
https://www.ncbi.nlm.nih.gov/pubmed/30997067
http://dx.doi.org/10.1002/ccr3.1997
_version_ 1783409301153382400
author Morita, Makiko
Nakanishi, Kayoko
Masuda, Kenta
Yoshida, Kazuhiro
Shimomura, Daiki
Ishida, Atsumi
Shiga, Shuichi
Ichiyama, Satoshi
author_facet Morita, Makiko
Nakanishi, Kayoko
Masuda, Kenta
Yoshida, Kazuhiro
Shimomura, Daiki
Ishida, Atsumi
Shiga, Shuichi
Ichiyama, Satoshi
author_sort Morita, Makiko
collection PubMed
description This report demonstrates that not only heparin‐induced thrombocytopenia, but also hemodialysis conditions (platelet activation due to hemodiafiltration and heparin underdosing) may markedly reduce the platelet count and cause clotting in the hemodialysis circuit in patients in a hypercoagulable state. The clot prevention effects of bortezomib are therefore of great importance.
format Online
Article
Text
id pubmed-6452500
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64525002019-04-17 Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma Morita, Makiko Nakanishi, Kayoko Masuda, Kenta Yoshida, Kazuhiro Shimomura, Daiki Ishida, Atsumi Shiga, Shuichi Ichiyama, Satoshi Clin Case Rep Case Reports This report demonstrates that not only heparin‐induced thrombocytopenia, but also hemodialysis conditions (platelet activation due to hemodiafiltration and heparin underdosing) may markedly reduce the platelet count and cause clotting in the hemodialysis circuit in patients in a hypercoagulable state. The clot prevention effects of bortezomib are therefore of great importance. John Wiley and Sons Inc. 2019-02-22 /pmc/articles/PMC6452500/ /pubmed/30997067 http://dx.doi.org/10.1002/ccr3.1997 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Morita, Makiko
Nakanishi, Kayoko
Masuda, Kenta
Yoshida, Kazuhiro
Shimomura, Daiki
Ishida, Atsumi
Shiga, Shuichi
Ichiyama, Satoshi
Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
title Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
title_full Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
title_fullStr Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
title_full_unstemmed Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
title_short Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
title_sort acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452500/
https://www.ncbi.nlm.nih.gov/pubmed/30997067
http://dx.doi.org/10.1002/ccr3.1997
work_keys_str_mv AT moritamakiko acutenonheparininducedthrombocytopeniaduringhemodiafiltrationinapatientwithmultiplemyeloma
AT nakanishikayoko acutenonheparininducedthrombocytopeniaduringhemodiafiltrationinapatientwithmultiplemyeloma
AT masudakenta acutenonheparininducedthrombocytopeniaduringhemodiafiltrationinapatientwithmultiplemyeloma
AT yoshidakazuhiro acutenonheparininducedthrombocytopeniaduringhemodiafiltrationinapatientwithmultiplemyeloma
AT shimomuradaiki acutenonheparininducedthrombocytopeniaduringhemodiafiltrationinapatientwithmultiplemyeloma
AT ishidaatsumi acutenonheparininducedthrombocytopeniaduringhemodiafiltrationinapatientwithmultiplemyeloma
AT shigashuichi acutenonheparininducedthrombocytopeniaduringhemodiafiltrationinapatientwithmultiplemyeloma
AT ichiyamasatoshi acutenonheparininducedthrombocytopeniaduringhemodiafiltrationinapatientwithmultiplemyeloma

Ejemplares similares